$0.352
-0.196 (-55.73%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
RVPH Prediction & Forecast by Similar Chart Analysis
Alphio's RVPH stock price prediction model matches the current Reviva Pharmaceuticals Holdings Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.35 (+0.43%). The 1-week path is $0.36 (+2.52%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Reviva Pharmaceuticals Holdings Inc Stock?
RVPH is not a good buy right now for a beginner with a long-term horizon and $50,000-$100,000 to invest. The stock is in a severe downtrend, the company is facing financing and listing risk, analysts have turned more cautious, and the current share price is far below key technical levels. Even though there are a few long-term pipeline positives, the balance of evidence says to avoid buying this stock now.
RVPH stock price ended at $0.35 on Wednesday, after losing -55.73%
Reviva Pharmaceuticals Holdings Inc (RVPH) last closed at $0.3521, losing -55.73%. These facts feed the 1-day and 1-week RVPH price prediction above.
Forecast Drivers
Reviva Pharmaceuticals Holdings Inc (RVPH) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bearish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches RVPH, ranked by similarity.
Seasonality analysis for RVPH
Historically the probability of a positive September return for RVPH is 0.00%. January offers the highest probability of a positive month at 24.59%, while March is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for RVPH
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Sep 2026 | $0.43 | $0.44 | $0.45 | +24.05% |
| Oct 2026 | $0.34 | $0.40 | $0.47 | +14.85% |
| Nov 2026 | $0.31 | $0.36 | $0.36 | +2.25% |
| Dec 2026 | $0.36 | $0.38 | $0.41 | +6.54% |
In 2026, Reviva Pharmaceuticals Holdings Inc (RVPH) is projected to range from $0.31 to $0.47.
Reviva Pharmaceuticals Holdings Inc 2026 monthly forecast
In Sep 2026, Reviva Pharmaceuticals Holdings Inc is projected to average $0.44, with a low of $0.43 and high of $0.45.
In Oct 2026, Reviva Pharmaceuticals Holdings Inc is projected to average $0.40, with a low of $0.34 and high of $0.47.
In Nov 2026, Reviva Pharmaceuticals Holdings Inc is projected to average $0.36, with a low of $0.31 and high of $0.36.
In Dec 2026, Reviva Pharmaceuticals Holdings Inc is projected to average $0.38, with a low of $0.36 and high of $0.41.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.